Until this week, Indian poultry farms had no vaccine made for the H5N1 bird flu strain that keeps returning to them. On Friday 20 November Union Agriculture Minister Shivraj Singh Chouhan launched one at a programme in Bhopal, Madhya Pradesh: India’s first indigenous H5N1 vaccine for chickens, developed in the same city by the ICAR-National Institute of High Security Animal Diseases (NIHSAD). The launch had been planned for Delhi, but Chouhan moved it to Bhopal because the scientists there had done the work.
The vaccine targets the H5N1 virus of clade 2.3.2.1a, a lineage of highly pathogenic avian influenza and the main strain found on Indian poultry farms; according to Insights IAS, no specific commercial vaccine for it existed in India or abroad. It is an inactivated, or killed-virus, vaccine. It contains virus particles that have been chemically made harmless and cannot multiply, yet they still train the chicken’s immune system to fight the real virus. Because the particles cannot replicate, the vaccine carries no risk of causing the infection itself. It was built from Indian virus samples collected since the country first detected H5N1 in 2006, and is designed for both commercial and backyard flocks.
The research took three years under strict biosafety rules: team members followed long sanitisation routines before going home, and were not allowed to keep other animals as pets. ICAR Director General Dr ML Jat estimated the price at Rs 1 to Rs 2 per dose, said talks with potential manufacturers on commercial production were under way, and hopes India can one day export the vaccine.
A cheap dose matters because the disease is common and deadly for birds. Chouhan said India has recorded more than 500 outbreaks of H5N1 and H5N8 bird flu since 2006. The first, at Navapur in Maharashtra, killed about 10 lakh chickens; nine lakh died in 2021 and two lakh this year, he said. Highly pathogenic bird flu can kill almost 100% of infected birds. To contain infection, farms have often had to cull, or kill, entire flocks. The vaccine is meant to prevent this, and is expected to help more than 90 lakh poultry farmers.
The wider stakes are economic and medical. Chouhan put yearly losses from livestock and poultry diseases at about Rs 56,000 crore, announced a Rs 300 crore modern laboratory in Bhopal, and called the vaccine “an example of India’s self-reliance.” The World Health Organization describes H5N1 as a flu virus that infects birds and mammals, and humans only in rare instances; the vaccine’s stated aims include curbing its spread from birds to mammals and humans.
Bird flu can kill almost all the chickens on a farm. To stop it spreading, farms have often had to kill whole flocks.
On 20 November India launched its own vaccine against the H5N1 bird flu virus. Scientists in Bhopal made it. It took three years.
The vaccine uses virus bits that have been made harmless. They cannot multiply. But they teach the chicken’s body to fight the real virus. Each dose may cost just Rs 1 to Rs 2. It could help more than 90 lakh poultry farmers.